Table 2.
Characteristics of the Validation Cohort
| Characteristic | Whole Cohort (N = 914) | Selected Cohort (N = 465) |
|---|---|---|
| Sex (male) | 678 (74.3) | 392 (81.2) |
| Age at HIV diagnosis (years) | 33 (27–40) | 33 (27–40) |
| LTNP-Ca | 468 (52.8) | 241 (51.8) |
| Interferon-lambda 4 A/A genotypeb | NA | 224 (48.2) |
| HLA-B*27 | 127 (14.2) | 94 (20) |
| HLA-B*57 | 268 (29.9) | 134 (28.6) |
| HLA-B*35 | 85 (9.5) | 46 (9.8) |
| HLA-B*08 | 74 (8.3) | 53 (11.3) |
Qualitative data are no. (%) of individuals. and quantitative data are median (interquartile range).
Abbreviations: HIV, human immunodeficiency virus; HLA, human leukocyte antigen; LTNP-C, long-term nonprogressor HIV-1 controller; NA, not available in the whole cohort.
aLTNP-C classification was possible for 887 patients.
bData were available for 465 individuals, for whom characteristics are listed in the right column.